ECF-Sponsored Research on Ocular Myeloma Recognized for 6,000 reads and references!
February 14, 2024: The Eye Cancer Foundation supported research on ocular myeloma has reached an astonishing 6,000 views on ResearchGate! This online professional network for scientists and researchers helps them connect and make it easy to share their scientific output, knowledge, and expertise.
Doctors at The New York Eye Cancer Center, started with 3 cases of ocular multiple myeloma, then reviewed the literature to reveal new facts and trends. Multiple myeloma is the most common plasma cell tumor; however, ocular plasmacytomas are rare and can appear in almost any structure of the eye. Obviously, there is a lot of interest in how and where plasmacytomas are presented in and around the eye.
Abstract
Background: Multiple myeloma is the most common plasma cell tumor; however, ocular plasmacytomas are rare and can appear in almost any structure of the eye. We present 3 cases, including 2 with unique ophthalmic ultrasound images of ocular plasmacytoma.
Case reports: Three patients with ocular manifestations of multiple myeloma are described. All were noted to have known synchronous systemic disease. In this study, patients presented with epibulbar (n = 2), iridociliary (n = 1), and orbital (n = 2) plasmacytomas. Presenting signs included clinically visible tumor (n = 2), blurred vision (n = 2), diplopia (n = 2), and glaucoma (n = 1). The iridociliary plasmacytoma was defined by high-frequency 35-MHz ultrasonography that revealed 360° of anterior chamber involvement, secondary angle-closure, and extent of iridociliary invasion. In another case, low-frequency B-scan ultrasonography found multiple myeloma of the orbit. Ocular manifestations of multiple myeloma, histopathology, treatment, and prognosis are described.
To read the full article and see the conclusion, please visit: https://pubmed.ncbi.nlm.nih.gov/21193351/
Doctors at The New York Eye Cancer Center, started with 3 cases of ocular multiple myeloma, then reviewed the literature to reveal new facts and trends. Multiple myeloma is the most common plasma cell tumor; however, ocular plasmacytomas are rare and can appear in almost any structure of the eye. Obviously, there is a lot of interest in how and where plasmacytomas are presented in and around the eye.
Abstract
Background: Multiple myeloma is the most common plasma cell tumor; however, ocular plasmacytomas are rare and can appear in almost any structure of the eye. We present 3 cases, including 2 with unique ophthalmic ultrasound images of ocular plasmacytoma.
Case reports: Three patients with ocular manifestations of multiple myeloma are described. All were noted to have known synchronous systemic disease. In this study, patients presented with epibulbar (n = 2), iridociliary (n = 1), and orbital (n = 2) plasmacytomas. Presenting signs included clinically visible tumor (n = 2), blurred vision (n = 2), diplopia (n = 2), and glaucoma (n = 1). The iridociliary plasmacytoma was defined by high-frequency 35-MHz ultrasonography that revealed 360° of anterior chamber involvement, secondary angle-closure, and extent of iridociliary invasion. In another case, low-frequency B-scan ultrasonography found multiple myeloma of the orbit. Ocular manifestations of multiple myeloma, histopathology, treatment, and prognosis are described.
To read the full article and see the conclusion, please visit: https://pubmed.ncbi.nlm.nih.gov/21193351/
